H.R. 2565
Referred to CommitteeFDA Modernization Act of 2021
Introduced 4/15/2021•117th Congress•House
Latest Action
Referred to the Subcommittee on Health.
4/16/2021 • House
Summary
FDA Modernization Act of 2021
This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, sophisticated computer modeling, and other human biology-based test methods.
Introduced in House • 4/15/2021
Enter your district to see how this bill affects your community
Topics & Subjects
Policy Area: Health
Animal protection and human-animal relationshipsCell biology and embryologyComputers and information technologyDrug safety, medical device, and laboratory regulationMedical researchMedical tests and diagnostic methodsResearch and development
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (115)
Party Breakdown
70
Democrats
45
Republicans
0
Independents
Sponsor
R[
Cosponsors (114)
R[
R[
R[
R[
R[
R[
Bill Journey
Originated in the House
Introduced
April 15, 2021
Referred to the House Committee on Energy and Commerce.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law
Text Versions (1)
Introduced in House4/15/2021